Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
TXMD

Market Cap: $25M

TI

TherapeuticsMD, Inc.

TXMD

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin89.94%

EBITDA Margin-1.28%

EBIT Margin-1.72%

Pre-tax Margin-8.04%

Net Profit Margin-6.64%

Earnings Yield-0.87%

Valuation Multiples

Price / Book0.92

Price / Sales7.65

Price / Earnings-114.89

PEG-0.11

Forward PEG-9.77

EV / Sales6.54

EV / EBITDA-5.09

EV / Operating Cash Flow6.85

EV / Free Cash Flow6.85

Price / Free Cash Flow8.01

Price / Operating Cash Flow8.01

Cash Flow & Capital

Free Cash Flow / Share$0.27

Operating Cash Flow / Share$0.27

Free Cash Flow Yield12.48%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.22

Quick Ratio3.22

Cash Ratio1.84

Debt / Assets0.15

Debt / Capital0.17

Debt / Equity0.20

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA0.86

Solvency Ratio0.12

Financial Leverage1.38

Efficiency & Working Capital

Asset Turnover0.09

Fixed Asset Turnover0.68

Inventory Turnover0.00

Receivables Turnover0.96

Payables Turnover0.72

Days Sales Outstanding378.84

Days Inventory Outstanding0

Days Payables Outstanding510.33

Operating Cycle378.84

Cash Conversion Cycle-131.49

Working Capital Turnover0.30

Returns & Quality

Return on Equity-0.80%

Return on Assets-0.58%

Return on Invested Capital-11.48%

ROCE-11.84%

Return on Tangible Assets-0.64%

Operating Return on Assets-10.26%

Income Quality-10.58

Tax Burden0.83

Interest Burden0.05

Balance Sheet & Intrinsic Metrics

Enterprise Value$21.37M

Invested Capital$19.51M

Working Capital$11.12M

Tangible Asset Value$23.57M

Net Current Asset Value$5.72M

Graham Number$0.9

Graham Net-Net$0.12

Book Value / Share$2.34

Tangible Book Value / Share$2.04

Cash / Share$0.79

Financial Health Scores

Piotroski Score4

Altman Z-Score-34.17

Revenue$3.27M

EBIT$-5.62M

Market Cap$24.31M

Working Capital$11.12M

Retained Earnings$-952.14M

Total Assets$37.53M

Total Liabilities$10.4M